Behzad Mahdavi, Ph.D., MBA, is Senior Vice President, Biopharma Manufacturing and Life Sciences Tools leading Ginkgo’s commercial efforts in the growing areas of bio-reagents, cell and gene therapies and new biopharmaceutical modalities. Dr. Mahdavi has more than 20 years of experience in developing and leading innovative patient-centric growth strategies in challenging environments in the biopharmaceutical, cell and gene therapy, personalized medicine and life sciences sectors and go-to advisor to technology start-ups and large companies.

He most recently served as Vice President of Global Open Innovation at Catalent Pharma Solutions. Prior to that, he held numerous leadership positions during his 13 years at Lonza. Before that, Dr. Mahdavi was CEO of SAM Electron Technologies. In addition to his company leadership roles, he has also served in multiple Board of Directors and Advisory Board roles. He holds a Chemistry Ph.D. from the University of Sherbrooke, Canada, and an MBA from the University of Quebec in Montreal.